EXFORGE
Novartis AG
| Research |
OneLook
Acronym Finder
|
| Serial Number | 78089458 |
| Registration Number | 2764146 |
| Mark Drawing Code | 1000: Typeset: Word(s)/letter(s)/number(s) |
| Domestic Representative | Novartis Pharmaceuticals Corporation |
| Attorney Name | Maury M. Tepper, III |
| Law Office Assigned | M30 |
| Employee Name | BLANDU, FLORENTINA |
Timeline
| 2001-10-22 | Application Filed |
| 2003-06-24 | Published for Opposition |
| 2003-09-16 | Trademark Registered |
| 2013-06-21 | Location: GENERIC WEB UPDATE |
| 2013-06-21 | Status: Live/Registered |
| 2013-09-16 | Renewal Date |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Novartis AG |
| Address | CH-4002 Basel CH |
| Legal Entity Type | Corporation |
| Legal Entity State | CH |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF DISORDERS OF [ THE CENTRAL NERVOUS SYSTEM, THE IMMUNE SYSTEM, ] THE CARDIO-VASCULAR SYSTEM [, THE RESPIRATORY SYSTEM, THE MUSCULO-SKELETAL SYSTEM, FOR THE TREATMENT OF INFLAMMATORY DISORDERS, FOR THE TREATMENT OF SKIN DISORDERS, FOR THE TREATMENT OF CANCER, AND FOR THE TREATMENT OF EYE DISORDERS ] |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| ASSIGNED TO EXAMINER | 2002-01-16 | 1 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION MAILED | 2002-02-01 | 2 CNRT F:First Action |
| PAPER RECEIVED | 2002-07-31 | 3 MAIL I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2002-07-31 | 4 CRFA I:Incoming Correspondence |
| LETTER OF SUSPENSION E-MAILED | 2002-09-06 | 5 GNSL S: |
| PAPER RECEIVED | 2003-03-03 | 6 MAIL I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2003-03-03 | 7 CRFA I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2003-03-24 | 8 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2003-03-25 | 9 CNSA O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2003-06-04 | 10 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2003-06-24 | 11 PUBO A:Allowance for Publication |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2003-06-30 | 12 TCCA I:Incoming Correspondence |
| REGISTERED-PRINCIPAL REGISTER | 2003-09-16 | 13 R.PR A:Allowance for Publication |
| PAPER RECEIVED | 2004-12-06 | 14 MAIL I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2004-12-19 | 15 TCCA I:Incoming Correspondence |
| CASE FILE IN TICRS | 2007-07-03 | 16 CFIT O:Outgoing Correspondence |
| TEAS SECTION 8 RECEIVED | 2009-02-12 | 17 ES8R I:Incoming Correspondence |
| ASSIGNED TO PARALEGAL | 2009-02-17 | 18 PLGL A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED | 2009-02-17 | 19 8.OK O:Outgoing Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2009-06-25 | 20 TCCA I:Incoming Correspondence |
| TEAS SECTION 8 & 9 RECEIVED | 2013-06-04 | 21 E89R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2013-06-21 | 22 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2013-06-21 | 23 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | 2013-06-21 | 24 RNL1 Q: |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | 2013-06-21 | 25 NA89 E:E-Mail |
| COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | 2022-09-16 | 26 REM2 E:E-Mail |
| TEAS SECTION 8 & 9 RECEIVED | 2023-01-27 | 27 E89R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2023-08-14 | 28 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2023-08-14 | 29 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) | 2023-08-14 | 30 RNL2 Q: |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | 2023-08-14 | 31 NA89 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 EXFORGE 78905845 3490550 Live/Registered |
Novartis AG 2006-06-12 |
 EXFORGE 78089458 2764146 Live/Registered |
Novartis AG 2001-10-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 